Oragenics (OGEN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.44, +0.00% vs the prior close of $0.44.
- Volume 11.60K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OGEN ends flat (+0.0%) to $0.44, 6 down days in a row. Closed at $0.44, +0.00% vs the prior close of $0.44. Day range $0.43–$0.46, opened at $0.43.
OGEN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — OGEN ends flat (+0.0%) to $0.44, 6 down days in a row
- Closed at $0.44, +0.00% vs the prior close of $0.44. Day range $0.43–$0.46, opened at $0.43.
- Volume was 11.60K shares, 0.4x its 50-day average of 30.67K — lighter than usual.
- Price is -12.9% vs its 50-day average ($0.50) and -30.4% vs its 200-day average ($0.63).
- 52-week range $0.43–$1.45; today's close sits at 1% of that range, 69.7% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — OGEN dips 2.2% to $0.44, a 52-week low, 5 down days in a row
- Closed at $0.44, -2.22% vs the prior close of $0.45. Day range $0.43–$0.45, opened at $0.45.
- Volume was 16.90K shares, 0.5x its 50-day average of 30.80K — lighter than usual.
- Price is -13.2% vs its 50-day average ($0.51) and -30.6% vs its 200-day average ($0.63).
- 52-week range $0.43–$1.45; today's close sits at 1% of that range, 69.7% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — OGEN ends flat (+0.0%) to $0.45, 4 down days in a row
- Closed at $0.45, +0.00% vs the prior close of $0.45. Day range $0.44–$0.45, opened at $0.45.
- Volume was 16.30K shares, 0.5x its 50-day average of 31.33K — lighter than usual.
- Price is -11.6% vs its 50-day average ($0.51) and -29.2% vs its 200-day average ($0.64).
- 52-week range $0.44–$1.45; today's close sits at 1% of that range, 69.0% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — OGEN dips 2.2% to $0.45, a 52-week low, 3 down days in a row
- Closed at $0.45, -2.17% vs the prior close of $0.46. Day range $0.45–$0.46, opened at $0.46.
- Volume was 17.20K shares, 0.5x its 50-day average of 31.82K — lighter than usual.
- Price is -11.9% vs its 50-day average ($0.51) and -29.4% vs its 200-day average ($0.64).
- 52-week range $0.45–$1.45; today's close sits at 0% of that range, 69.0% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — OGEN ends flat (+0.0%) to $0.46
- Closed at $0.46, +0.00% vs the prior close of $0.46. Day range $0.45–$0.48, opened at $0.47.
- Volume was 28.20K shares, 0.9x its 50-day average of 31.57K.
- Price is -10.1% vs its 50-day average ($0.51) and -28.1% vs its 200-day average ($0.64).
- 52-week range $0.45–$1.45; today's close sits at 1% of that range, 68.3% below the 52-week high.
Oct 8, 2026 — OGEN slides 8.0% to $0.46, a 52-week low
- Closed at $0.46, -8.00% vs the prior close of $0.50. Day range $0.46–$0.50, opened at $0.50.
- Volume was 45.80K shares, 1.5x its 50-day average of 30.82K.
- Price is -10.2% vs its 50-day average ($0.51) and -28.3% vs its 200-day average ($0.64).
- 52-week range $0.46–$1.45; today's close sits at 0% of that range, 68.3% below the 52-week high.
Oct 7, 2026 — OGEN rises 2.0% to $0.50
- Closed at $0.50, +2.04% vs the prior close of $0.49. Day range $0.49–$0.50, opened at $0.50.
- Volume was 11.60K shares, 0.4x its 50-day average of 31.12K — lighter than usual.
- Price is -2.6% vs its 50-day average ($0.51) and -22.3% vs its 200-day average ($0.64).
- 52-week range $0.46–$1.45; today's close sits at 4% of that range, 65.5% below the 52-week high.
Oct 6, 2026 — OGEN ends flat (+0.0%) to $0.49
- Closed at $0.49, +0.00% vs the prior close of $0.49. Day range $0.48–$0.49, opened at $0.49.
- Volume was 12.30K shares, 0.4x its 50-day average of 31.19K — lighter than usual.
- Price is -4.5% vs its 50-day average ($0.51) and -24.1% vs its 200-day average ($0.65).
- 52-week range $0.46–$1.45; today's close sits at 3% of that range, 66.2% below the 52-week high.
Oct 5, 2026 — OGEN ends flat (+0.0%) to $0.49
- Closed at $0.49, +0.00% vs the prior close of $0.49. Day range $0.48–$0.50, opened at $0.48.
- Volume was 42.30K shares, 1.4x its 50-day average of 30.61K.
- Price is -4.6% vs its 50-day average ($0.51) and -24.3% vs its 200-day average ($0.65).
- 52-week range $0.46–$1.45; today's close sits at 3% of that range, 66.2% below the 52-week high.
Oct 2, 2026 — OGEN rises 2.1% to $0.49
- Closed at $0.49, +2.08% vs the prior close of $0.48. Day range $0.48–$0.50, opened at $0.48.
- Volume was 15.40K shares, 0.5x its 50-day average of 30.62K — lighter than usual.
- Price is -4.6% vs its 50-day average ($0.51) and -24.5% vs its 200-day average ($0.65).
- 52-week range $0.46–$1.45; today's close sits at 3% of that range, 66.2% below the 52-week high.
OGEN latest news & SEC filings
Every SEC filing by or about OGEN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$2.53M (prior year -$2.27M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.57 (prior year -$3.10) (loss narrowed vs Jun 30, 2025)
Jul 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade OGEN
- How much it moves: over the last 20 sessions the average daily move was 2.63% (largest 8.3%).
- Liquidity: about 25.75K shares (≈$11.33K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.44 vs a range of $0.43–$1.45 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Jun 3, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 2 sales; latest: Fred Telling sold 210 shares on Dec 12, 2025.
- Latest filings: 8-K Sep 16, 2026; 8-K Aug 28, 2026; 10-Q Aug 13, 2026.
- Share count: 4.51M shares outstanding (Aug 12, 2026), +9.3% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
OGEN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.43 | 0.46 | 0.43 | 0.44 | 11.60K |
| Oct 14, 2026 | 0.45 | 0.45 | 0.43 | 0.44 | 16.90K |
| Oct 13, 2026 | 0.45 | 0.45 | 0.44 | 0.45 | 16.30K |
| Oct 12, 2026 | 0.46 | 0.46 | 0.45 | 0.45 | 17.20K |
| Oct 9, 2026 | 0.47 | 0.48 | 0.45 | 0.46 | 28.20K |
| Oct 8, 2026 | 0.50 | 0.50 | 0.46 | 0.46 | 45.80K |
| Oct 7, 2026 | 0.50 | 0.50 | 0.49 | 0.50 | 11.60K |
| Oct 6, 2026 | 0.49 | 0.49 | 0.48 | 0.49 | 12.30K |
| Oct 5, 2026 | 0.48 | 0.50 | 0.48 | 0.49 | 42.30K |
| Oct 2, 2026 | 0.48 | 0.50 | 0.48 | 0.49 | 15.40K |
| Oct 1, 2026 | 0.49 | 0.52 | 0.48 | 0.48 | 32.40K |
| Sep 30, 2026 | 0.48 | 0.50 | 0.47 | 0.49 | 14.40K |
| Sep 29, 2026 | 0.49 | 0.49 | 0.46 | 0.48 | 42.00K |
| Sep 28, 2026 | 0.51 | 0.51 | 0.46 | 0.47 | 33.30K |
| Sep 25, 2026 | 0.52 | 0.52 | 0.48 | 0.49 | 11.80K |
| Sep 24, 2026 | 0.49 | 0.50 | 0.49 | 0.50 | 17.40K |
| Sep 23, 2026 | 0.52 | 0.53 | 0.49 | 0.49 | 40.00K |
| Sep 22, 2026 | 0.52 | 0.53 | 0.50 | 0.52 | 25.30K |
| Sep 21, 2026 | 0.48 | 0.52 | 0.48 | 0.52 | 37.90K |
| Sep 18, 2026 | 0.50 | 0.52 | 0.48 | 0.48 | 43.00K |
About Oragenics
Oragenics (OGEN) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LAKEWOOD RANCH, FL. State of incorporation: FL. Fiscal year ends December 31. SEC CIK 1174940.
OGEN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Alan W Dunton | Director | Dec 15, 2025 |
| John P Gandolfo | Director | Dec 15, 2025 |
| Natasha Giordano | Director | Dec 15, 2025 |
| Robert C Koski | Director | Dec 15, 2025 |
| Charles L Pope | Director | Dec 15, 2025 |
| Fred Telling | Director | Jan 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Janet Huffman | CEO and CFO | Dec 15, 2025 |
| John Spencer | Chief Financial Officer | Jul 7, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 12, 2025 | Fred Telling | Sale | 210 | $0.94 |
| Dec 12, 2025 | Fred Telling | Sale | 210 | $0.94 |
OGEN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-9.84M | -4.56 | $-9.25M |
| Dec 31, 2024 | — | $-10.57M | -47.88 | $-8.60M |
| Dec 31, 2023 | $37.65K | $-20.66M | -9.18 | $-7.29M |
| Dec 31, 2022 | $131.52K | $-14.29M | -7.11 | $-15.23M |
| Dec 31, 2021 | $86.99K | $-15.71M | — | $-13.47M |
Latest balance sheet: total assets $5.49M, total liabilities $1.82M, cash $3.86M (as of Jun 30, 2026).
OGEN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on OGEN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.